Craft
GC Pharma

GC Pharma

Stock Price

₩119.8 K

2023-02-28

Market Capitalization

₩1.4 T

2023-02-28

Revenue

₩1.5 T

FY, 2021

GC Pharma Summary

Company summary

Overview
GC Pharma (formerly known as Green Cross Corporation, 녹십자) is a biopharmaceutical company that delivers protein therapeutics and vaccines. It develops and exports a variety of plasma-derived products, including albumin, immunoglobulin, and antithrombin.
Type
Public
Status
Active
Founded
1967
HQ
Yongin-si, KR | view all locations
Website
http://www.globalgreencross.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Yongin-si, Gyeonggi-do HQ

    Korea (Republic of)

    107 Ihyeon-ro 30-beongil, Giheung-gu

GC Pharma Financials

Summary financials

Revenue (Q2, 2022)
₩836.3B
Gross profit (Q2, 2022)
₩296.8B
Net income (Q2, 2022)
₩29.6B
Cash (Q3, 2022)
₩162.0B
EBIT (Q2, 2022)
₩56.8B
Enterprise value
$1.9T

Footer menu